Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
7
8
9
10
11
12
13
14
15
16
17
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
293
586
879
1172
1465
1758
2051
2344
2637
2930
vopikitug
(RG6292) / Roche
177Lu-DTPA-omburtamab
/ Y-mAbs Therap
211At-OKT10-B10
/ Fred Hutchinson Cancer Center
225Ac-DOTA-daratumumab
/ City of Hope
90Y-besilesomab
(TLX66) / Telix
A-319
/ ITabMed
A-337
/ ITabMed
ABBV-319
/ AbbVie
ABP-300
/ Abpro, BIO invest, Mabwell (Shanghai) Biosci
AFM11
/ Affimed
AGEN1777
/ Agenus
AGEN2373
/ Agenus, Gilead
AGS67E
/ Astellas, Pfizer
AMP-224
/ GSK
AMT-116 ADC
/ Multitude Therap
AO-176
/ Arch Oncology
AP203
/ AP Biosciences
ASP1002
/ Astellas
ATA3219
/ Atara
ATLCAR.CD30.CCR4 cells
/ UNC Lineberger Comprehensive Cancer Center
AUTO3
/ Autolus
AWT020
/ Anwita Biosci
AdCD40L
/ Uppsala University
Anti CEA/CD30 CAR-T
/ Shanghai First Song Therap
Anti-CD19 CAR-T
/ First Affiliated Hospital of Nanchang University
Anti-CD22 CAR-T Cells
/ Beijing Boren Hospital
Antova
(ruplizumab) / Biogen
Autologous CAR-T cells
/ UTC Therap
B019
/ Shanghai Pharma
BA1104
(nivolumab biosimilar) / Luye Group
BAT4306F
/ Bio-Thera Solutions
BAT7104
/ Bio-Thera Solutions
BCMA-CD19 cCAR T cells
/ iCell Gene Therap
BEAM-201
/ Beam Therap
BGB-B167
/ BeiGene
BND-22
/ Biond Biologics
BNT142
/ BioNTech
BPI-1178
/ Beta Pharma
BRL-201
/ BRL Medicine
BRL-303
/ BRL Medicine
BS006
/ Wuhan Binhui Biotech
BinD19
/ Shenzhen BinDeBio
C7R-GD2.CART cells
/ Baylor College of Medicine
CART-138
/ Chinese PLA General Hospital
CART-19/22
/ Shanghai Unicar
CART-33
/ Chinese PLA General Hospital
CB-010
/ Caribou Biosci
CB307
/ Crescendo Biologics
CBG-006
/ Carbiogene Therap
CC-90002
/ Inhibrx Biosci, BMS
«
1
2
...
7
8
9
10
11
12
13
14
15
16
17
...
27
28
»
